|
HY-130189-100mg
|
MedChemexpress LLC
|
S-Phenylmercapturic acid [CAS 4775-80-8]
|
|
|
|
|
HY-W011777-500mg
|
MedChemexpress LLC
|
Tricaine (methanesulfonate) [CAS 886-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W011777-1mL
|
MedChemexpress LLC
|
Tricaine (methanesulfonate) [CAS 886-86-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-129047A-100ug
|
MedChemexpress LLC
|
Trypsin (MS grade) [CAS 9002-07-7]
|
|
COVID-19-anti-virus
|
|
|
HY-123023-25ug
|
MedChemexpress LLC
|
12(S)-HETE D8 [CAS 84807-90-9]
|
|
|
|
|
HY-140381-100mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-250mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-50mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-10mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-100mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-25mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-5mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-50mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13010-10mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-100mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-5mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-50mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-500mg
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13010-1mL
|
MedChemexpress LLC
|
Laquinimod [CAS 248281-84-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
